|
|
Changes of Serum CA125 VEGF-C and Sex Hormone Levels before and after Hysteromyoma Surgery and the Relationship with Prognosis |
XU Han |
Liaoyang Central Hospital, Liaoning Liaoyang 111000, China |
|
|
Abstract Objective: To observe the changes of serum cancer antigen (CA125), vascular endothelial growth factor-C (VEGF-C) and sex hormone levels before and after the operation of hysteromyoma, and to study the relationship between these three indexes and the prognosis of patients. Methods: From January 2017 to may 2018, 120 cases of hysteromyoma in our hospital were selected for surgical treatment as the study object. All patients underwent laparoscopic myomectomy, Serum CA125, VEGF-C, follicular stimulating hormone (FSH), luteinizing hormone (LH), progesterone (P), estradiol (E2) levels were compared between the two groups before and 7 days after operation, and the pregnancy of patients with pregnancy requirements (n = 75) and those without pregnancy requirements (n = 75) within 12 months after operation were followed up (n = 45). Results: The levels of serum CA125, VEGF-C, P and E2 in all patients were significantly lower than those before operation (P<0.05 or P<0.01), and the levels of serum FSH and LH were significantly higher than those before operation (P<0.05 or P<0.01). The follow-up results showed that the menstrual volume, dysmenorrhea and other clinical symptoms of 120 patients were significantly improved. Conclusion: Surgical treatment of hysteromyoma can effectively improve the changes of serum CA125, VEGF-C and sex hormone levels, and improve the prognosis of patients.
|
|
|
|
|
[1] 刘林燕,袁胜涛,余伯阳,等.子宫肌瘤发生机制及相关治疗研究进展[J].中国临床药理学与治疗学,2017,12(2):140~146. [2] 张亚丽.传统开腹手术与腹腔镜子宫肌瘤剔除术治疗子宫肌瘤的临床效果比较[J].中国卫生标准管理,2017,8(22):69~70. [3] 张梅霞,康丽娜,李文东.子宫肌瘤患者血清性激素水平的变化分析及临床研究[J].现代养生,2017,23(4):142. [4] 谢幸,苟文丽.妇产科学[M].第8版.人民卫生出版社,2013.145~147. [5] 赵菁,肖霞.子宫肌瘤发病的危险因素分析[J].山东医药,2017,57(14):94~95. [6] 付立业,田昕,李妍,等.血清人附睾分泌蛋白4(HE4)和CA125在卵巢癌患者围手术期的变化及临床意义[J].现代肿瘤医学,2017,14(20):3295~3298. [7] 陈晓萍,赵莉.转化生长因子β激活酶1在子宫肌瘤组织中的表达及意义[J].海南医学院学报,2016,22(6):583~585,588. [8] 郎景和,冷金花,王泽华,等.促性腺激素释放激素激动剂在子宫内膜异位症和子宫平滑肌瘤治疗中的应用专家意见[J].中华妇产科杂志,2017,65(2):77~81. |
|
|
|